AJMC October 21, 2022
Allison Inserro

Coverage from the New York City presentation of the Institute for Value-Based Medicine, co-chaired by Emeline Aviki, MD, MBA, of Memorial Sloan Kettering Cancer Center (MSKCC), and Robert Daly, MD, MBA, medical oncologist and lung cancer specialist at MSKCC.

Eight days before the deadline for applications to join the next iteration of the CMS’ value-based payment model for oncology, physician-researchers and other stakeholders gathered in midtown Manhattan to discuss affordability, technology, and innovation in cancer care.

In June 2022, CMS announced that the successor to the Oncology Care Model (OCM) would be the Enhancing Oncology Model (EOM), to launch July 1, 2023. The OCM allowed practices to learn the model before taking on 2-sided risk on a voluntary basis, but...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Healthcare System, Payment Models, Provider, Public Health / COVID, Value Based
Understanding CMS’ AHEAD Model: Medicare Hospital Global Budget Design and Implications
How extending virtual options can drive value-based care
Health system C-suites eye value-based care roles
Incentivizing Provider Engagement for Improved Value-Based Outcomes
201: Value series: What does health system VBC adoption actually look like?

Share This Article